Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has been given an average rating of “Buy” by the fifteen ratings firms that are currently covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation, two have given a hold recommendation, nine have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $56.90.
Several research analysts have recently issued reports on ACHC shares. BidaskClub raised Acadia Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, July 1st. William Blair started coverage on Acadia Healthcare in a research note on Tuesday, July 18th. They set an “outperform” rating for the company. Mizuho lifted their price target on Acadia Healthcare from $57.00 to $60.00 and gave the stock a “buy” rating in a research note on Friday, July 28th. UBS AG reaffirmed a “positive” rating and set a $60.00 price target (up previously from $54.00) on shares of Acadia Healthcare in a research note on Monday, July 31st. Finally, Craig Hallum reaffirmed a “buy” rating and set a $65.00 price target (up previously from $52.00) on shares of Acadia Healthcare in a research note on Monday, July 31st.
In related news, insider Scott Schwieger sold 2,891 shares of Acadia Healthcare stock in a transaction dated Monday, July 31st. The stock was sold at an average price of $52.85, for a total transaction of $152,789.35. Following the completion of the sale, the insider now owns 8,841 shares in the company, valued at approximately $467,246.85. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Reeve B. Waud sold 1,240,000 shares of Acadia Healthcare stock in a transaction dated Monday, July 31st. The stock was sold at an average price of $51.72, for a total value of $64,132,800.00. The disclosure for this sale can be found here. In the last quarter, insiders have sold 3,085,693 shares of company stock valued at $157,729,099. 11.10% of the stock is currently owned by company insiders.
WARNING: This report was reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this report on another domain, it was illegally copied and reposted in violation of US & international trademark & copyright legislation. The legal version of this report can be accessed at https://www.com-unik.info/2017/10/12/acadia-healthcare-company-inc-achc-receives-consensus-recommendation-of-buy-from-analysts.html.
Shares of Acadia Healthcare (NASDAQ:ACHC) opened at 43.62 on Thursday. The stock’s 50 day moving average is $46.33 and its 200-day moving average is $46.36. Acadia Healthcare has a 12-month low of $32.54 and a 12-month high of $54.34. The stock has a market cap of $3.83 billion, a price-to-earnings ratio of 479.34 and a beta of 1.07.
Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Thursday, July 27th. The company reported $0.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.65 by $0.01. The business had revenue of $715.90 million during the quarter, compared to the consensus estimate of $717.38 million. Acadia Healthcare had a return on equity of 8.69% and a net margin of 0.30%. The business’s revenue was down 5.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.73 EPS. Equities analysts anticipate that Acadia Healthcare will post $2.45 EPS for the current fiscal year.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
What are top analysts saying about Acadia Healthcare Company Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Acadia Healthcare Company Inc. and related companies.